1-3 of 3
Guy Cantin, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chemosensitive Disease Better Predicts Outcome Than Age Following Autologous Heamatopoietic Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Christopher Lemieux, MD, Robert Delage, MD, Guy Cantin, MD, Frederic Barabe, MD, Vincent Laroche, MD, Rémy Angers, BSc, Genevieve Gallagher, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5530.
https://doi.org/10.1182/blood.V130.Suppl_1.5530.5530
Published: 2017
Journal Articles

Safety and Efficacy of Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the GREEN Study

Veronique Leblond, Guy Cantin, MD, Agostino Cortelezzi, Prof, Wolfgang Knauf, Mourad Tiab, Mehmet Turgut, MD, Andrey Zaritskey, Jean-Louis Merot, Kerstin Trunzer, Susan Robson, Ekaterina Gresko, Stephan Stilgenbauer, MD PhD, Robin Foà, Francesc Bosch
Journal: Blood
Blood (2017) 130 (Supplement 1): 3015.
https://doi.org/10.1182/blood.V130.Suppl_1.3015.3015
Published: 2017
Journal Articles

Bortezomib Added to CVP-R Is Safe and Effective for Previously Untreated Advanced Stage Follicular Lymphoma: A Phase II Study by the NCIC Clinical Trials Group.

Laurie H. Sehn, MD, MPH, David A Macdonald, MD, Sheldon H. Rubin, MD, Guy Cantin, MD, Morel Rubinger, MD, Bernard Lemieux, MD, Sanraj Basi, MD, Kevin R Imrie, MD, Randy D. Gascoyne, Bingshu Chen, PhD, Marina Djurfeldt, MSc, Lois Shepherd, MD, Stephen Couban, MD, Michael Crump, MD
Journal: Blood
Blood (2009) 114 (22): 407.
https://doi.org/10.1182/blood.V114.22.407.407
Published: 2009